Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EverBiome is a Munich-based biotechnology company specializing in the analysis and modulation of the human microbiome. A spin-off from the Technical University of Munich, the company utilizes a proprietary high-throughput screening and AI-driven platform to identify functional microbial signatures associated with health and disease. EverBiome offers Microbiome-as-a-Service to partners while developing its own pipeline of live biotherapeutic products and diagnostic tools. Their primary focus is on restoring gut health and addressing dysbiosis through personalized microbial interventions. The company aims to bridge the gap between microbiome research and clinical application by providing scalable, data-driven solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EverBiome.